In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was achieved with minimal disruption and substantial cost saving to our healthcare partners.
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).